Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 166

1.

Breast Cancer Disparities Among Women in Underserved Communities in the USA.

Thompson B, Hohl SD, Molina Y, Paskett ED, Fisher JL, Baltic RD, Washington CM.

Curr Breast Cancer Rep. 2018 Sep;10(3):131-141. doi: 10.1007/s12609-018-0277-8. Epub 2018 Aug 29.

2.

Assessing the Impact of CALGB 9343 on Surgical Trends in Elderly-Women With Stage I ER+ Breast Cancer: A SEER-Based Analysis.

Bazan JG, Fisher JL, Park KU, Marcus EA, Bittoni MA, White JR.

Front Oncol. 2019 Jul 9;9:621. doi: 10.3389/fonc.2019.00621. eCollection 2019.

3.

Novel Benzodiazepine-Like Ligands with Various Anxiolytic, Antidepressant, or Pro-Cognitive Profiles.

Prevot TD, Li G, Vidojevic A, Misquitta KA, Fee C, Santrac A, Knutson DE, Stephen MR, Kodali R, Zahn NM, Arnold LA, Scholze P, Fisher JL, Marković BD, Banasr M, Cook JM, Savic M, Sibille E.

Mol Neuropsychiatry. 2019 Apr;5(2):84-97. doi: 10.1159/000496086. Epub 2019 Jan 23.

4.

Change in Policy Allowing Overlapping Surgery Decreases Length of Stay in an Academic, Safety-Net Hospital.

DiGiorgio AM, Mummaneni PV, Fisher JL, Podet AG, Crutcher CL, Virk MS, Fang Z, Wilson JD, Tender GC, Culicchia F.

Oper Neurosurg (Hagerstown). 2019 Mar 28. pii: opz009. doi: 10.1093/ons/opz009. [Epub ahead of print]

PMID:
30919890
5.

Correlates of Rural, Appalachian, and Community Identity in the CITIES Cohort.

Paskett ED, Young GS, Bernardo BM, Washington C, DeGraffinreid C, Fisher JL, Huerta TR.

J Rural Health. 2019 Mar;35(2):167-175. doi: 10.1111/jrh.12347. Epub 2019 Mar 4.

PMID:
30830989
6.

The association between histological subtype of a first primary endometrial cancer and second cancer risk.

Rhoades J, Vetter MH, Fisher JL, Cohn DE, Salani R, Felix AS.

Int J Gynecol Cancer. 2019 Feb;29(2):290-298. doi: 10.1136/ijgc-2018-000014. Epub 2018 Dec 21.

7.

The CITIES Project: Understanding the Health of Underrepresented Populations in Ohio.

Paskett ED, Young GS, Bernardo BM, Washington C, DeGraffinreid CR, Fisher JL, Huerta TR.

Cancer Epidemiol Biomarkers Prev. 2019 Mar;28(3):442-454. doi: 10.1158/1055-9965.EPI-18-0793. Epub 2018 Oct 30.

PMID:
30377208
8.

Identifying patterns of care for elderly patients with non-surgically treated stage III non-small cell lung cancer: an analysis of the national cancer database.

Miller ED, Fisher JL, Haglund KE, Grecula JC, Xu-Welliver M, Bertino EM, He K, Shields PG, Carbone DP, Williams TM, Otterson GA, Bazan JG.

Radiat Oncol. 2018 Oct 5;13(1):196. doi: 10.1186/s13014-018-1142-7.

9.

Esophageal Adenocarcinoma: Opportunities for Targeted Prevention in Ohio.

Stephens JA, Fisher JL, Krok-Schoen JL, Baltic RD, Sobotka HL, Paskett ED.

Clin Med Insights Gastroenterol. 2018 Jul 30;11:1179552218791170. doi: 10.1177/1179552218791170. eCollection 2018.

10.

Bioisosteres of ethyl 8-ethynyl-6-(pyridin-2-yl)-4H-benzo[f]imidazo [1,5-a][1,4]diazepine-3-carboxylate (HZ-166) as novel alpha 2,3 selective potentiators of GABAA receptors: Improved bioavailability enhances anticonvulsant efficacy.

Witkin JM, Smith JL, Ping X, Gleason SD, Poe MM, Li G, Jin X, Hobbs J, Schkeryantz JM, McDermott JS, Alatorre AI, Siemian JN, Cramer JW, Airey DC, Methuku KR, Tiruveedhula VVNPB, Jones TM, Crawford J, Krambis MJ, Fisher JL, Cook JM, Cerne R.

Neuropharmacology. 2018 Jul 15;137:332-343. doi: 10.1016/j.neuropharm.2018.05.006. Epub 2018 May 3.

PMID:
29778948
11.

VISTA expression on tumor-infiltrating inflammatory cells in primary cutaneous melanoma correlates with poor disease-specific survival.

Kuklinski LF, Yan S, Li Z, Fisher JL, Cheng C, Noelle RJ, Angeles CV, Turk MJ, Ernstoff MS.

Cancer Immunol Immunother. 2018 Jul;67(7):1113-1121. doi: 10.1007/s00262-018-2169-1. Epub 2018 May 8.

PMID:
29737375
12.

An antidepressant-related pharmacological signature for positive allosteric modulators of α2/3-containing GABAA receptors.

Methuku KR, Li X, Cerne R, Gleason SD, Schkeryantz JM, Tiruveedhula VVNPB, Golani LK, Li G, Poe MM, Rahman MT, Cook JM, Fisher JL, Witkin JM.

Pharmacol Biochem Behav. 2018 Jul;170:9-13. doi: 10.1016/j.pbb.2018.04.009. Epub 2018 Apr 30.

PMID:
29715490
13.

Incidence and survival of hematological cancers among adults ages ≥75 years.

Krok-Schoen JL, Fisher JL, Stephens JA, Mims A, Ayyappan S, Woyach JA, Rosko AE.

Cancer Med. 2018 Apr 13. doi: 10.1002/cam4.1461. [Epub ahead of print]

14.

Disparities in breast cancer tumor characteristics, treatment, time to treatment, and survival probability among African American and white women.

Foy KC, Fisher JL, Lustberg MB, Gray DM, DeGraffinreid CR, Paskett ED.

NPJ Breast Cancer. 2018 Mar 20;4:7. doi: 10.1038/s41523-018-0059-5. eCollection 2018.

15.

A Novel Orally Available Asthma Drug Candidate That Reduces Smooth Muscle Constriction and Inflammation by Targeting GABAA Receptors in the Lung.

Forkuo GS, Nieman AN, Kodali R, Zahn NM, Li G, Rashid Roni MS, Stephen MR, Harris TW, Jahan R, Guthrie ML, Yu OB, Fisher JL, Yocum GT, Emala CW, Steeber DA, Stafford DC, Cook JM, Arnold LA.

Mol Pharm. 2018 May 7;15(5):1766-1777. doi: 10.1021/acs.molpharmaceut.7b01013. Epub 2018 Apr 2.

16.

Recent Advances in the Acute Management of Intracerebral Hemorrhage.

Burns JD, Fisher JL, Cervantes-Arslanian AM.

Neurosurg Clin N Am. 2018 Apr;29(2):263-272. doi: 10.1016/j.nec.2017.11.005. Review.

PMID:
29502716
17.

The Addition of Chemotherapy to Radiation Therapy Improves Survival in Elderly Patients with Stage III Non-Small Cell Lung Cancer.

Miller ED, Fisher JL, Haglund KE, Grecula JC, Xu-Welliver M, Bertino EM, He K, Shields PG, Carbone DP, Williams TM, Otterson GA, Bazan JG.

J Thorac Oncol. 2018 Mar;13(3):426-435. doi: 10.1016/j.jtho.2017.11.135. Epub 2018 Jan 8.

18.

Ethnic disparities in cancer incidence and survival among the oldest old in the United States.

Krok-Schoen JL, Adams IK, Baltic RD, Fisher JL.

Ethn Health. 2017 Oct 27:1-14. doi: 10.1080/13557858.2017.1395818. [Epub ahead of print]

PMID:
29076352
19.

Recent Advances in the Acute Management of Intracerebral Hemorrhage.

Burns JD, Fisher JL, Cervantes-Arslanian AM.

Neurol Clin. 2017 Nov;35(4):737-749. doi: 10.1016/j.ncl.2017.06.009. Review.

PMID:
28962811
20.

Phenological and distributional shifts in ichthyoplankton associated with recent warming in the northeast Pacific Ocean.

Auth TD, Daly EA, Brodeur RD, Fisher JL.

Glob Chang Biol. 2018 Jan;24(1):259-272. doi: 10.1111/gcb.13872. Epub 2017 Sep 26.

PMID:
28948709
21.

White-Black Differences in Cancer Incidence, Stage at Diagnosis, and Survival Among Older Adults.

Krok-Schoen JL, Fisher JL, Baltic RD, Paskett ED.

J Aging Health. 2018 Jul;30(6):863-881. doi: 10.1177/0898264317696777. Epub 2017 Mar 21.

22.

NKG2D Ligand-Targeted Bispecific T-Cell Engagers Lead to Robust Antitumor Activity against Diverse Human Tumors.

Godbersen C, Coupet TA, Huehls AM, Zhang T, Battles MB, Fisher JL, Ernstoff MS, Sentman CL.

Mol Cancer Ther. 2017 Jul;16(7):1335-1346. doi: 10.1158/1535-7163.MCT-16-0846. Epub 2017 May 12.

23.

Antinociceptive Effects of a Novel α2/α3-Subtype Selective GABAA Receptor Positive Allosteric Modulator.

Lewter LA, Fisher JL, Siemian JN, Methuku KR, Poe MM, Cook JM, Li JX.

ACS Chem Neurosci. 2017 Jun 21;8(6):1305-1312. doi: 10.1021/acschemneuro.6b00447. Epub 2017 Feb 13.

24.

Immune modulation associated with vascular endothelial growth factor (VEGF) blockade in patients with glioblastoma.

Thomas AA, Fisher JL, Hampton TH, Christensen BC, Tsongalis GJ, Rahme GJ, Whipple CA, Steel SE, Davis MC, Gaur AB, Lewis LD, Ernstoff MS, Fadul CE.

Cancer Immunol Immunother. 2017 Mar;66(3):379-389. doi: 10.1007/s00262-016-1941-3. Epub 2016 Dec 9.

PMID:
27942839
25.

Epithelial-Mesenchymal Expression Phenotype of Primary Melanoma and Matched Metastases and Relationship with Overall Survival.

Yan S, Holderness BM, Li Z, Seidel GD, Gui J, Fisher JL, Ernstoff MS.

Anticancer Res. 2016 Dec;36(12):6449-6456.

26.

White-Black Differences in Cancer Incidence, Stage at Diagnosis, and Survival among Adults Aged 85 Years and Older in the United States.

Krok-Schoen JL, Fisher JL, Baltic RD, Paskett ED.

Cancer Epidemiol Biomarkers Prev. 2016 Nov;25(11):1517-1523. Epub 2016 Aug 15.

27.

PDE11A negatively regulates lithium responsivity.

Pathak G, Agostino MJ, Bishara K, Capell WR, Fisher JL, Hegde S, Ibrahim BA, Pilarzyk K, Sabin C, Tuczkewycz T, Wilson S, Kelly MP.

Mol Psychiatry. 2017 Dec;22(12):1714-1724. doi: 10.1038/mp.2016.155. Epub 2016 Sep 20.

28.

Flagship umbrella species needed for the conservation of overlooked aquatic biodiversity.

Kalinkat G, Cabral JS, Darwall W, Ficetola GF, Fisher JL, Giling DP, Gosselin MP, Grossart HP, Jähnig SC, Jeschke JM, Knopf K, Larsen S, Onandia G, Pätzig M, Saul WC, Singer G, Sperfeld E, Jarić I.

Conserv Biol. 2017 Apr;31(2):481-485. doi: 10.1111/cobi.12813. Epub 2016 Dec 16. No abstract available.

29.

The mitogen-activated protein kinase pathway plays a critical role in regulating immunological properties of BRAF mutant cutaneous melanoma cells.

Whipple CA, Boni A, Fisher JL, Hampton TH, Tsongalis GJ, Mellinger DL, Yan S, Tafe LJ, Brinckerhoff CE, Turk MJ, Mullins DW, Fadul CE, Ernstoff MS.

Melanoma Res. 2016 Jun;26(3):223-35. doi: 10.1097/CMR.0000000000000244.

PMID:
26974965
30.

The auxiliary subunits Neto1 and Neto2 have distinct, subunit-dependent effects at recombinant GluK1- and GluK2-containing kainate receptors.

Fisher JL.

Neuropharmacology. 2015 Dec;99:471-80. doi: 10.1016/j.neuropharm.2015.08.018. Epub 2015 Aug 13.

31.

Delivery of marine larvae to shore requires multiple sequential transport mechanisms.

Pfaff MC, Branch GM, Fisher JL, Hoffmann V, Ellis AG, Largier JL.

Ecology. 2015 May;96(5):1399-410.

PMID:
26236852
32.

The impact of El Niño events on the pelagic food chain in the northern California Current.

Fisher JL, Peterson WT, Rykaczewski RR.

Glob Chang Biol. 2015 Dec;21(12):4401-14. doi: 10.1111/gcb.13054.

PMID:
26220498
33.

Response to "the epidemiology of glioma in adults: a 'state of the science' review".

Ostrom QT, Bauchet L, Davis FG, Deltour I, Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA, Turner MC, Walsh KM, Wrensch MR, Barnholtz-Sloan JS.

Neuro Oncol. 2015 Apr;17(4):624-6. doi: 10.1093/neuonc/nov022. No abstract available.

34.

Regulatory T cells are not a strong predictor of survival for patients with glioblastoma.

Thomas AA, Fisher JL, Rahme GJ, Hampton TH, Baron U, Olek S, Schwachula T, Rhodes CH, Gui J, Tafe LJ, Tsongalis GJ, Lefferts JA, Wishart H, Kleen J, Miller M, Whipple CA, de Abreu FB, Ernstoff MS, Fadul CE.

Neuro Oncol. 2015 Jun;17(6):801-9. doi: 10.1093/neuonc/nou363. Epub 2015 Jan 24.

35.

Primary care physician supply, insurance type, and late-stage cancer diagnosis.

Plascak JJ, Fisher JL, Paskett ED.

Am J Prev Med. 2015 Feb;48(2):174-178. doi: 10.1016/j.amepre.2014.08.014. Epub 2014 Oct 29.

36.

Childhood brain tumor epidemiology: a brain tumor epidemiology consortium review.

Johnson KJ, Cullen J, Barnholtz-Sloan JS, Ostrom QT, Langer CE, Turner MC, McKean-Cowdin R, Fisher JL, Lupo PJ, Partap S, Schwartzbaum JA, Scheurer ME.

Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2716-36. doi: 10.1158/1055-9965.EPI-14-0207. Epub 2014 Sep 5. Review.

37.

Contributions of different kainate receptor subunits to the properties of recombinant homomeric and heteromeric receptors.

Fisher MT, Fisher JL.

Neuroscience. 2014 Oct 10;278:70-80. doi: 10.1016/j.neuroscience.2014.08.009. Epub 2014 Aug 17.

38.

Letter to the editor.

Fadul CE, Fisher JL, Hampton TH, Ernstoff MS.

J Immunother Cancer. 2014 Jul 15;2:22. doi: 10.1186/2051-1426-2-22. eCollection 2014. No abstract available.

39.

Vaccine-based immunotherapy for glioblastoma.

Thomas AA, Fisher JL, Ernstoff MS, Fadul CE.

CNS Oncol. 2013 Jul;2(4):331-49. doi: 10.2217/cns.13.29. Review.

40.

The neurotoxin domoate causes long-lasting inhibition of the kainate receptor GluK5 subunit.

Fisher JL.

Neuropharmacology. 2014 Oct;85:9-17. doi: 10.1016/j.neuropharm.2014.05.003. Epub 2014 May 20.

41.

The epidemiology of glioma in adults: a "state of the science" review.

Ostrom QT, Bauchet L, Davis FG, Deltour I, Fisher JL, Langer CE, Pekmezci M, Schwartzbaum JA, Turner MC, Walsh KM, Wrensch MR, Barnholtz-Sloan JS.

Neuro Oncol. 2014 Jul;16(7):896-913. Review.

42.

Loud noise exposure and acoustic neuroma.

Fisher JL, Pettersson D, Palmisano S, Schwartzbaum JA, Edwards CG, Mathiesen T, Prochazka M, Bergenheim T, Florentzson R, Harder H, Nyberg G, Siesjö P, Feychting M.

Am J Epidemiol. 2014 Jul 1;180(1):58-67. doi: 10.1093/aje/kwu081. Epub 2014 Apr 30.

PMID:
24786799
43.

Evaluation of web-based, self-administered, graphical food frequency questionnaire.

Kristal AR, Kolar AS, Fisher JL, Plascak JJ, Stumbo PJ, Weiss R, Paskett ED.

J Acad Nutr Diet. 2014 Apr;114(4):613-21. doi: 10.1016/j.jand.2013.11.017. Epub 2014 Jan 24.

44.

Multiple murine BRaf(V600E) melanoma cell lines with sensitivity to PLX4032.

Jenkins MH, Steinberg SM, Alexander MP, Fisher JL, Ernstoff MS, Turk MJ, Mullins DW, Brinckerhoff CE.

Pigment Cell Melanoma Res. 2014 May;27(3):495-501. doi: 10.1111/pcmr.12220. Epub 2014 Mar 6. No abstract available.

45.

Comorbid conditions associated with glioblastoma.

Fisher JL, Palmisano S, Schwartzbaum JA, Svensson T, Lönn S.

J Neurooncol. 2014 Feb;116(3):585-91. doi: 10.1007/s11060-013-1341-x. Epub 2014 Jan 11.

PMID:
24414135
46.

Rural residence and cancer outcomes in the United States: issues and challenges.

Meilleur A, Subramanian SV, Plascak JJ, Fisher JL, Paskett ED, Lamont EB.

Cancer Epidemiol Biomarkers Prev. 2013 Oct;22(10):1657-67. doi: 10.1158/1055-9965.EPI-13-0404. Review.

47.

Polytherapy with stiripentol: consider more than just metabolic interactions.

Mott DD, Grosenbaugh DK, Fisher JL.

Epilepsy Behav. 2013 Dec;29(3):585. doi: 10.1016/j.yebeh.2013.09.008. Epub 2013 Oct 2. No abstract available.

PMID:
24094845
48.

A phase I, dose-escalation study of cyclical weekly oral temozolomide and weekly PEG-interferon alpha-2b in patients with refractory or advanced solid tumours.

Coker SA, Dandamudi UB, Beelen AP, Crosby NA, Fisher JL, Obrocea M, Ernstoff MS, Lewis LD.

J Chemother. 2013 Dec;25(6):362-8. doi: 10.1179/1973947813Y.0000000102. Epub 2013 Dec 6.

PMID:
24093213
49.

Agonist binding to the GluK5 subunit is sufficient for functional surface expression of heteromeric GluK2/GluK5 kainate receptors.

Fisher JL, Housley PR.

Cell Mol Neurobiol. 2013 Nov;33(8):1099-108. doi: 10.1007/s10571-013-9976-x. Epub 2013 Aug 23.

50.

SB-205384 is a positive allosteric modulator of recombinant GABAA receptors containing rat α3, α5, or α6 subunit subtypes coexpressed with β3 and γ2 subunits.

Heidelberg LS, Warren JW, Fisher JL.

J Pharmacol Exp Ther. 2013 Oct;347(1):235-41. doi: 10.1124/jpet.113.207324. Epub 2013 Jul 31.

Supplemental Content

Loading ...
Support Center